假馬齒莧 Bacopa Monnieri × 注意力不足過動症
結論：證據分歧
假馬齒莧用於兒童 ADHD 僅有少量小型印度試驗與機轉合理性支撐：最強的 2022 雙盲 RCT（n=93）行為主要結果未達顯著，正向訊號集中於次要認知/睡眠指標且為廠商資助；Kean 2016 SR 效應量小至中（d=0.
C 🟠 C 薄弱證據 證據分歧 ✨ low — community discussion mostly non-commercial
假馬齒莧用於兒童 ADHD 僅有少量小型印度試驗與機轉合理性支撐：最強的 2022 雙盲 RCT（n=93）行為主要結果未達顯著，正向訊號集中於次要認知/睡眠指標且為廠商資助；Kean 2016 SR 效應量小至中（d=0.42），Dave 2014 為 open-label n=31。
整體符合『機轉合理＋少量人體研究＋學會認定證據不足』的 C 級錨點，不足以升至 B。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.54
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 證據分歧
信心度
77%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.537
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Effects of Bacopa monnieri (CDRI 08) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial
結論：No significant behavioral group differences; CDRI 08 favored on decreased error-making (p=.04), cognitive flexibility (p=.01), executive functioning (p=.04), interpersonal problems (p=.02) and sleep routine (p=.04).
前往 PubMed
A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations
結論：Five studies; significant improvements in hyperactivity and attention-deficit domains, with overall small-to-medium effect (mean d=0.42); authors call for more rigorous replication.
前往 PubMed
An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children
結論：Restlessness reduced in 93%, self-control improved in 89%, attention-deficit reduced in 85%; 74% had up to 20% reduction and 26% had 21-50% reduction in total symptom score.
前往 PubMed
Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis
結論：Seven RCTs in children/adolescents; Bacopa monnieri among herbs with fair indication of efficacy/safety, but overall inadequate proof to strongly recommend herbal therapy for ADHD.
前往 PubMed
L4a US FDA
謹慎
L4b EU EFSA
未表態
— 本適應症無對應資料
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
中性
— 本適應症無對應資料
L4e WHO
未表態
— 本適應症無對應資料
L5a NIH Office of Dietary Supplements
未表態
— 本適應症無對應資料
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
中性
— 本適應症無對應資料
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
反對
There is not enough evidence that these herbs and supplements decrease ADHD symptoms, however. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 低度
低中高
📍立場總覽
假馬齒莧（Bacopa monnieri）在台灣社群屬冷門成分，PTT（健身/regimen/醫療各版）、Dcard、Mobile01 均查無針對「ADHD／注意力不足過動症」的實質討論串，鄉民也無集體實測心得。搜尋結果集中於維基百科、MSD 等醫學參考資料與少數益智藥（聰明藥）科普文章，以及 Amazon 等海外電商上架的複方益智補充品列表；台灣本土幾乎無人單獨討論「假馬齒莧用於過動」此用途。因社群討論不足，依規範不杜撰鄉民發言，全數欄位設為空，stance 判為 not_addressed。
💬社群實感
無共識（台灣社群幾無相關討論，無法歸納實測心得）
- 中樞神經興奮劑藥物
- 行為治療／親職行為訓練
- 非興奮劑藥物（atomoxetine、guanfacine）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-adhd-INT-bacopa-monnieri-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "假馬齒莧能改善注意力不足過動症",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}